Podcast – COVID-19 Vaccine: Why Has the Centre Termed Additional Doses as ‘Precautionary’
Dr. Rakesh Mishra in an exclusive with the The Big Story by The Quint
27Dec
Related Posts
11Jun
A-post-Covid-19 social protection architecture for India,Hindustan Times,11 Jun 2020
https://www.hindustantimes.com/analysis/a-post-covid-19-social-protection-architecture-for-india/story-BCt1POzFojnKloCkHTsv9H.html read more
17Nov
TIGS at Bengaluru Tech Summit 2022
Dr. Farah Ishtiaq, Principal Scientist, TIGS was a panelist on 'OneHealth and... read more
28Jul
DBT/Wellcome Trust India Alliance Early Career Fellowship to Dr. Shivranjani Moharir
We are pleased to announce that Dr. Shivranjani Moharir, Senior Scientist, TIGS... read more
22Dec
कोरोना का नया वैरिएंट BF.7 भारत के लिए कितनी बड़ी चुनौती है?
कोरोना का नया वैरिएंट BF.7 भारत के लिए कितनी बड़ी चुनौती है?... read more
06Dec
Healthcare to agriculture: How genome revolution could be game changer
Dr. Rakesh Mishra, Director at TIGS, and Dr. Saveetha Meganathan, Research Scientist at... read more
10Nov
Demystifying Vaccines: Evolution of mRNA-Based Platforms In Vaccines and Therapeutics
TIGS Scientists, Dr. Arati Ramesh and Dr. Rajesh Iyer, participated in the... read more
17Aug
Antimicrobial Resistance has become a ‘silent pandemic’
Speaking to The Hindu, Dr. Rakesh Mishra, Director, TIGS highlights the threat... read more
05Mar
White Paper: Enabling a More Effective Ecosystem of Innovation and Care for Rare Diseases
Click to access the document On 28th February 2026, at Genetics Decoded, a... read more
28Jul
TIGS and CSIR – North East Institute Of Science And Technology (NEIST) ink MoU
In the face of climate change, research on plant disease diagnostics, AMR... read more
20Oct
Stem Cell technology offers new hope for treating rare genetic disorders
Stem cell technology has witnessed advancement that open new hopes for the... read more